SCHEDULE 13G/A: Oasis Management and Seth Fischer Disclose 13% Passive Stake in Global Cord Blood Corp
Beneficial Ownership Report
Oasis Management Company Ltd. and Seth Fischer have filed an amended Schedule 13G, reporting a 13.0% passive beneficial ownership stake in Global Cord Blood Corp.
Summary
- Oasis Management Company Ltd. and Seth Fischer have filed an Amendment No. 3 to Schedule 13G, disclosing their beneficial ownership in Global Cord Blood Corp.
- The reporting persons collectively beneficially own 17,389,516 Ordinary Shares of Global Cord Blood Corp.
- This represents a 13.0% stake in the company's Ordinary Shares.
- The percentage is calculated based on 133,914,711 Ordinary Shares outstanding as of July 31, 2022, as reported in the company's Annual Report of Foreign Private Issuer on Form 20-F.
- Both Oasis Management and Seth Fischer hold shared voting power and shared dispositive power over these 17,389,516 shares.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing disclosing a passive ownership stake, providing no direct positive or negative operational or financial news.
Positives
- The disclosure of a significant 13.0% stake by Oasis Management Company Ltd. and Seth Fischer indicates a notable institutional investment in Global Cord Blood Corp.
- The filing confirms that the investment is passive, suggesting the investors are not seeking to influence or change the control of the company, which can provide stability.
Risks
- The document itself does not detail specific operational or financial risks related to Global Cord Blood Corp.
- As a passive investment, the reporting persons do not intend to influence management or corporate strategy, which might limit potential for shareholder-driven changes.
Future Outlook
The document is a beneficial ownership report and does not contain any forward-looking statements or guidance from the company or the reporting persons regarding the company's future outlook.
Industry Context
Global Cord Blood Corp operates in the specialized healthcare sector of cord blood banking, which involves the collection, processing, and storage of umbilical cord blood for potential future medical use. This industry is characterized by long-term storage contracts and a focus on medical advancements and research.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant ownership stakes, confirming a substantial passive investment by Oasis Management Company Ltd. and Seth Fischer.
Key Dates
| Date | Description |
|---|---|
| 07/31/2022 | Date as of which 133,914,711 Ordinary Shares outstanding were reported in the company's Form 20-F, used for percentage calculation. |
| 03/31/2025 | Date of event which required the filing of this statement. |
| 05/15/2025 | Date of filing and signature of the Schedule 13G Amendment No. 3. |
Keywords
Global Cord Blood Corp, Oasis Management Company Ltd, Seth Fischer, Schedule 13G, Beneficial Ownership, Passive Investment, Healthcare, Biotechnology, Cord Blood Banking
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.